These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27513300)

  • 121. Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.
    Lam PY; Nissen MD; Mattarollo SR
    Front Immunol; 2017; 8():1355. PubMed ID: 29109728
    [TBL] [Abstract][Full Text] [Related]  

  • 122. Phenotype of NK-Like CD8(+) T Cells with Innate Features in Humans and Their Relevance in Cancer Diseases.
    Barbarin A; Cayssials E; Jacomet F; Nunez NG; Basbous S; Lefèvre L; Abdallah M; Piccirilli N; Morin B; Lavoue V; Catros V; Piaggio E; Herbelin A; Gombert JM
    Front Immunol; 2017; 8():316. PubMed ID: 28396661
    [TBL] [Abstract][Full Text] [Related]  

  • 123. The Hypothesis of the Human iNKT/Innate CD8(+) T-Cell Axis Applied to Cancer: Evidence for a Deficiency in Chronic Myeloid Leukemia.
    Jacomet F; Cayssials E; Barbarin A; Desmier D; Basbous S; Lefèvre L; Levescot A; Robin A; Piccirilli N; Giraud C; Guilhot F; Roy L; Herbelin A; Gombert JM
    Front Immunol; 2016; 7():688. PubMed ID: 28138330
    [TBL] [Abstract][Full Text] [Related]  

  • 124. The rho-kinase inhibitors Y-27632 and fasudil act synergistically with imatinib to inhibit the expansion of ex vivo CD34(+) CML progenitor cells.
    Burthem J; Rees-Unwin K; Mottram R; Adams J; Lucas GS; Spooncer E; Whetton AD
    Leukemia; 2007 Aug; 21(8):1708-14. PubMed ID: 17554385
    [TBL] [Abstract][Full Text] [Related]  

  • 125. Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients.
    Rossignol A; Levescot A; Jacomet F; Robin A; Basbous S; Giraud C; Roy L; Guilhot F; Turhan AG; Barra A; Herbelin A; Gombert JM
    Eur J Immunol; 2012 Jul; 42(7):1870-5. PubMed ID: 22585600
    [TBL] [Abstract][Full Text] [Related]  

  • 126. Development, Function, and Clinical Significance of Plasmacytoid Dendritic Cells in Chronic Myeloid Leukemia.
    Inselmann S; Wang Y; Saussele S; Fritz L; Schütz C; Huber M; Liebler S; Ernst T; Cai D; Botschek S; Brendel C; Calogero RA; Pavlinic D; Benes V; Liu ET; Neubauer A; Hochhaus A; Burchert A
    Cancer Res; 2018 Nov; 78(21):6223-6234. PubMed ID: 30166420
    [TBL] [Abstract][Full Text] [Related]  

  • 127. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
    Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
    Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
    [TBL] [Abstract][Full Text] [Related]  

  • 128. The Rho-ROCK pathway as a new pathological mechanism of innate immune subversion in chronic myeloid leukaemia.
    Basbous S; Levescot A; Piccirilli N; Brizard F; Guilhot F; Roy L; Bourmeyster N; Gombert JM; Herbelin A
    J Pathol; 2016 Nov; 240(3):262-268. PubMed ID: 27513300
    [TBL] [Abstract][Full Text] [Related]  

  • 129. Bcr-Abl tyrosine kinase inhibitors: a patent review.
    Desogus A; Schenone S; Brullo C; Tintori C; Musumeci F
    Expert Opin Ther Pat; 2015 Apr; 25(4):397-412. PubMed ID: 25656651
    [TBL] [Abstract][Full Text] [Related]  

  • 130. Important therapeutic targets in chronic myelogenous leukemia.
    Kantarjian HM; Giles F; Quintás-Cardama A; Cortes J
    Clin Cancer Res; 2007 Feb; 13(4):1089-97. PubMed ID: 17317816
    [TBL] [Abstract][Full Text] [Related]  

  • 131. BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: a review.
    An X; Tiwari AK; Sun Y; Ding PR; Ashby CR; Chen ZS
    Leuk Res; 2010 Oct; 34(10):1255-68. PubMed ID: 20537386
    [TBL] [Abstract][Full Text] [Related]  

  • 132. Treatment of chronic myeloid leukemia with imatinib mesylate.
    Ohno R
    Int J Clin Oncol; 2006 Jun; 11(3):176-83. PubMed ID: 16850123
    [TBL] [Abstract][Full Text] [Related]  

  • 133. Dendritic cells from patients with chronic myeloid leukemia: functional and phenotypic features.
    Eisendle K; Wolf D; Gastl G; Kircher-Eibl B
    Leuk Lymphoma; 2005 May; 46(5):663-70. PubMed ID: 16019503
    [TBL] [Abstract][Full Text] [Related]  

  • 134. [Research advance on molecular genetics of CML blast crisis].
    Zhu HQ; Zhang S; Liu XL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935
    [TBL] [Abstract][Full Text] [Related]  

  • 135.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 136.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 137.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 138.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 139.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 140.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.